Stage IVB Colon Cancer Completed Phase 1 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0028588 (Stage IVB Colon Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00060411A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerTreatment